News

Three-time Emmy winner and Oscar nominee Patricia Clarkson ("Pieces of April," "Six Feet Under") stars in "Lilly," a biopic about the activist who fought for equal pay while working as a supervisor at ...
The woman who fought for women to be paid the same as men for equal work has died. Lilly Ledbetter, namesake of the 2009 Fair Pay Act, was 86. Ledbetter was the plaintiff in the Supreme Court case ...
GADSDEN, Ala. — Lilly Ledbetter, a women's equality activist whose sex discrimination lawsuit against her employer culminated in a major equal wage legislation bearing her name, has died.
The film “Lilly,” a biopic about the equal pay icon Lilly Ledbetter, lands in theaters at a difficult time for her biggest political and civil rights champions. Most are gone or out of power ...
“The 2025 Trends in Investing Survey provides a crucial snapshot of how financial planners are navigating today's market and economy,” said Paul Brahim, president of the FPA. Survey ...
A clinical trial showed that Lilly's weight loss medicine is superior to a key competitor's product. The drug giant has several other selling points, including a deep lineup and pipeline.
Pretty much everyone on the show—other than Michaela—wears Lilly Pulitzer, to the point where you might be wondering...literally why. And apparently creator Molly Smith Metzler was simply ...
In a passing of the torch, Olympic 200m breaststroke champion Kate Douglass overtook Lilly King, the 100m breast world record holder, in the 100m event in King’s final career domestic race at the ...
Eli Lilly is expanding its efforts to advance next-generation pain medications. The Big Pharma has penned a deal to acquire SiteOne Therapeutics, primarily for a non-opioid pain asset ready to ...
Eli Lilly and Co. announced plans on Tuesday to acquire private biotechnology company San Francisco-based SiteOne Therapeutics Inc. in a deal worth up to $1 billion. SiteOne, founded in 2010 ...
Eli Lilly's growth is impressive, driven by Mounjaro and Zepbound, but its current valuation is only justifiable with sustained high growth. Despite strong results and superior products ...
Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. The pharma giant's presence across several treatment areas has helped it grow ...